Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

Share Price is delayed by 15 minutes
Get Live Data
1,280.80    -30.60 (-2.33%)
Bid:
1,280.20
Ask:
1,280.60
Spread: 0.40 (0.031%)
Market Cap: £219.63b
HSBA Live PriceLast checked at - London Stock Exchange

Intraday HSBC Holdings Share Chart

Director Declaration

5 Apr 2024 10:00

RNS Number : 5023J
HSBC Holdings PLC
05 April 2024
 

 

 

 

 

 

5 April 2024

 

HSBC HOLDINGS PLC

DIRECTOR DECLARATION

 

 

In accordance with UK Listing Rule 9.6.14 R(2), HSBC Holdings plc ('HSBC') confirms that Rachel Duan, a non-executive Director of HSBC, has been nominated as a non-executive Director of Kering SA with effect from 25 April 2024, subject to shareholder approval at Kering's AGM on the same day.

 

If approved by Kering shareholders, the appointment will temporarily result in Rachel holding five directorships, with HSBC remaining her main commitment. Rachel has confirmed that she will be stepping down from one of her other listed positions by the end of 2024.

 

In authorising this appointment, the Board reviewed the total time commitment expected of Ms Duan across all roles. The Board remains comfortable that Ms Duan retains sufficient capacity to fulfil her duties to HSBC effectively during this period. Since joining the Board in September 2021, Ms Duan has attended all scheduled Board meetings of the HSBC Board of Directors.

 

For and on behalf of

HSBC Holdings plc

 

 

Aileen Taylor

Group Company Secretary and Chief Governance Officer

 

 

Investor enquiries to:

Neil Sankoff +44 (0) 20 7991 5072 investorrelations@hsbc.com

Yafei Tian +852 2899 8909 yafei.tian@hsbc.com.hk

 

Media enquiries to:

HSBC press office +44 (0) 20 79918096 pressoffice@hsbc.com

 

 

Notes to editors:

The Board of Directors of HSBC Holdings plc as at the date of this announcement comprises:

Mark Edward Tucker*, Noel Paul Quinn, Geraldine Joyce Buckingham†, Rachel Duan†, Georges Bahjat Elhedery, Dame Carolyn Julie Fairbairn†, James Anthony Forese†, Ann Frances Godbehere†, Steven Craig Guggenheimer†, Dr José Antonio Meade Kuribreña†, Kalpana Jaisingh Morparia†, Eileen K Murray†, Brendan Robert Nelson†, David Thomas Nish† and Swee Lian Teo†.

 

* Non-executive Group Chairman

 Independent non-executive Director

 

HSBC Holdings plc, the parent company of the HSBC, is headquartered in London. HSBC serves customers worldwide from offices in 62 countries and territories. With assets of US$3,039bn at 31 December 2023, HSBC is one of the world's largest banking and financial services organisations.

 

ends/all

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNMZGGDRKRGDZG
Date   Source Headline
3rd Apr 20255:56 pmRNSTransaction in Own Shares
2nd Apr 20255:48 pmRNSTransaction in Own Shares
1st Apr 20255:52 pmRNSTransaction in Own Shares
31st Mar 20255:42 pmRNSTransaction in Own Shares
31st Mar 20253:00 pmRNSTotal Voting Rights
31st Mar 20252:00 pmRNSBOCOM Proposed Issuance of A Shares
28th Mar 20255:42 pmRNSTransaction in Own Shares
28th Mar 20253:00 pmRNSDirector/PDMR Shareholding
28th Mar 20251:05 pmRNSPublication of Base Prospectus
27th Mar 20255:55 pmRNSTransaction in Own Shares
26th Mar 20256:06 pmRNSTransaction in Own Shares
25th Mar 20255:49 pmRNSTransaction in Own Shares
25th Mar 202510:00 amRNSOverseas Regulatory Announcement - Grant of Awards
24th Mar 20255:46 pmRNSTransaction in Own Shares
24th Mar 20254:00 pmRNSDirector/PDMR Shareholding
24th Mar 20259:00 amRNSSecurities issuance - closing announcement
21st Mar 20255:59 pmRNSTransaction in Own Shares
21st Mar 202510:00 amRNS2025 AGM - Documents available at NSM
21st Mar 20257:00 amRNSIssuance of contingent convertible securities
20th Mar 20256:00 pmRNSTransaction in Own Shares
19th Mar 20255:55 pmRNSTransaction in Own Shares
19th Mar 202510:00 amRNSHong Kong Waiver-Contingent Convertible Securities
18th Mar 20255:45 pmRNSTransaction in Own Shares
17th Mar 20255:33 pmRNSTransaction in Own Shares
14th Mar 20255:48 pmRNSTransaction in Own Shares
13th Mar 20255:35 pmRNSTransaction in Own Shares
13th Mar 20253:30 pmRNSDirector/PDMR Shareholding
12th Mar 20255:40 pmRNSTransaction in Own Shares
12th Mar 20253:30 pmRNSDirector/PDMR Shareholding
11th Mar 20255:48 pmRNSTransaction in Own Shares
11th Mar 20253:10 pmRNSIssuance of subordinated unsecured notes
10th Mar 20255:59 pmRNSTransaction in Own Shares
7th Mar 20255:57 pmRNSTransaction in Own Shares
7th Mar 20253:30 pmRNSNotice of redemption
7th Mar 20259:00 amRNSGroup reporting changes
6th Mar 20255:48 pmRNSTransaction in Own Shares
6th Mar 202511:01 amRNSDirector/PDMR Shareholding
6th Mar 202511:00 amRNSOverseas Regulatory Announcement - Grant of Awards
5th Mar 20255:46 pmRNSTransaction in Own Shares
4th Mar 20255:58 pmRNSTransaction in Own Shares
4th Mar 20254:00 pmRNSDirector/PDMR Shareholding
3rd Mar 20255:33 pmRNSTransaction in Own Shares
3rd Mar 20254:00 pmRNSIssuance of senior unsecured notes
28th Feb 20255:55 pmRNSTransaction in Own Shares
28th Feb 20253:01 pmRNSTotal Voting Rights
28th Feb 20253:00 pmRNSDirector/PDMR Shareholding
27th Feb 20255:57 pmRNSTransaction in Own Shares
27th Feb 20254:35 pmRNSIssuance of contingent convertible securities
26th Feb 20255:52 pmRNSTransaction in Own Shares
25th Feb 20255:45 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.